Stay updated with breaking news from Nasdaq Blte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stock analysts at SVB Leerink started coverage on shares of Belite Bio (NASDAQ:BLTE – Get Free Report) in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage set an “outperform” rating and a $25.00 price target on the stock. SVB Leerink’s price target would indicate a potential upside of 34.26% […]
Belite Bio (NASDAQ:BLTE – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Benchmark in a research report issued on Tuesday, Benzinga reports. They currently have a $57.00 price objective on the stock. Benchmark’s price target would suggest a potential upside of 193.97% from the company’s previous close. Separately, HC Wainwright […]
Belite Bio (NASDAQ:BLTE – Get Free Report) and GeoVax Labs (NASDAQ:GOVX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings and institutional ownership. Volatility & Risk Belite Bio has a […]
Belite Bio (NASDAQ:BLTE – Get Rating) had its target price reduced by HC Wainwright from $58.00 to $55.00 in a report issued on Monday, The Fly reports. HC Wainwright also issued estimates for Belite Bio’s Q2 2023 earnings at ($0.18) EPS, Q3 2023 earnings at ($0.19) EPS, Q4 2023 earnings at ($0.21) EPS, FY2023 earnings […]
Belite Bio, Inc (NASDAQ:BLTE – Get Rating) – Research analysts at HC Wainwright issued their Q1 2024 EPS estimates for Belite Bio in a report released on Monday, June 5th. HC Wainwright analyst Y. Chen expects that the company will earn ($0.23) per share for the quarter. The consensus estimate for Belite Bio’s current full-year […]